Search
Search results
28 results found
News Headline 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus...
Lorem Ipsum
Lorem Ipsum, MD Co-creation targeted collaborate, triple bottom line radical segmentation.
Lorem Ipsum
Lorem Ipsum, MD Co-creation targeted collaborate, triple bottom line radical segmentation.
Jenny Serra-Vinardell
Inaugural Merkin Prize in Biomedical Technology Celebrated at the Broad Institute of MIT and Harvard
BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.
Rauh, Ulrike, Guo Wei, Michael Serrano-Wu, Georgios Kosmidis, Stefan Kaulfuss, Franziska Siegel, Kai Thede, et al. 2024. “BRD-810 Is a Highly Selective MCL1 Inhibitor With Optimized in Vivo Clearance and Robust Efficacy in Solid and Hematological Tumor Models.”. Nat Cancer 5: 1479-93.